About Institut Central des Hopitaux Valaisans
"L’Institut Central des Hôpitaux regroupe de nombreuses missions transversales réalisées pour les établissements de l’Hôpital du Valais et de l’Hôpital Riviera-Chablais Vaud/Valais, ainsi que pour d’autres partenaires du système sanitaire tels que les médecins privés, le Service cantonal de la santé publique, la Clinique Romande de Réadaptation, les établissements médico-sociaux (homes pour personnes âgées) ou les centres médico-sociaux (suivi médicalisé à domicile)."
Clinical Trials at Institut Central des Hopitaux Valaisans
During the past decade, Institut Central des Hopitaux Valaisans conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Central des Hopitaux Valaisans"
#1 collaborator was "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Institut Central des Hopitaux Valaisans
According to Clinical.Site data, the most researched conditions in "Institut Central des Hopitaux Valaisans" are
"Breast Cancer" (1 trials), "Leukemia" (1 trials), "Palmar-plantar Erythrodysesthesia" (1 trials), "Pancreatic Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Institut Central des Hopitaux Valaisans" in a lesser frequency.
Clinical Trials Intervention Types at Institut Central des Hopitaux Valaisans
Most popular intervention types in "Institut Central des Hopitaux Valaisans" are "Drug" (4 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Exemestane" (1 trials), "Exemestane+bicalutamide" (1 trials), "Gemcitabine + Capecitabine" (1 trials), "Gemcitabine alone" (1 trials) and "allogeneic bone marrow transplantation" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Central des Hopitaux Valaisans
The vast majority of trials in "Institut Central des Hopitaux Valaisans" are
3 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Institut Central des Hopitaux Valaisans
Currently, there are NaN active trials in "Institut Central des Hopitaux Valaisans".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Institut Central des Hopitaux Valaisans,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Central des Hopitaux Valaisans, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".